De Broe ME - Search Results

1

Aminoglycoside nephrotoxicity: mechanism and prevention.

De Broe ME, Giuliano RA, Verpooten GA. De Broe ME, et al. Adv Exp Med Biol. 1989;252:233-45. doi: 10.1007/978-1-4684-8953-8_22. Adv Exp Med Biol. 1989. PMID: 2675552 Review. No abstract available.

2

Once-daily dosing decreases renal accumulation of gentamicin and netilmicin.

Verpooten GA, Giuliano RA, Verbist L, Eestermans G, De Broe ME. Verpooten GA, et al. Among authors: de broe me. Clin Pharmacol Ther. 1989 Jan;45(1):22-7. doi: 10.1038/clpt.1989.4. Clin Pharmacol Ther. 1989. PMID: 2910634

3

Pathogenesis of dialysis-induced hypoxemia: a short overview.

De Broe ME, Heyrman RM, De Backer WA, Verpooten GA, Vermeire PA. De Broe ME, et al. Among authors: de backer wa. Kidney Int Suppl. 1988 Mar;24:S57-61. Kidney Int Suppl. 1988. PMID: 3129613 Review. No abstract available.

4

Effect of hyperfiltration, proteinuria and diabetes mellitus on the uptake kinetics of gentamicin in the kidney cortex of rats.

Pattyn VM, Verpooten GA, Giuliano RA, Zheng F, De Broe ME. Pattyn VM, et al. Among authors: de broe me. J Pharmacol Exp Ther. 1988 Feb;244(2):694-8. J Pharmacol Exp Ther. 1988. PMID: 3346842

5

Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.

De Broe ME, Giuliano RA, Verpooten GA. De Broe ME, et al. Am J Med. 1986 Jun 30;80(6B):115-8. doi: 10.1016/0002-9343(86)90488-2. Am J Med. 1986. PMID: 3728523

6

Kinetics of the renal cortical uptake and release of aminoglycosides: a rational approach to the understanding and prevention of their nephrotoxicity.

Giuliano RA, Verpooten GA, De Broe ME. Giuliano RA, et al. Among authors: de broe me. Dev Toxicol Environ Sci. 1986;14:105-14. Dev Toxicol Environ Sci. 1986. PMID: 3829968 No abstract available.

7

Prospective comparative study of the nephrotoxicity of aminoglycosides in human (abstract).

De Broe ME, Paulus G, Verpooten GA, Roels F, Van Hoof F, Tulkens P. De Broe ME, et al. J Antimicrob Chemother. 1981 Jul;8 Suppl A:111-3. doi: 10.1093/jac/8.suppl_a.111. J Antimicrob Chemother. 1981. PMID: 7263557 No abstract available.

8

Decreased renal epidermal growth factor expression in cyclosporine-treated rats.

Deng JT, Verpooten GA, Malesys J, Verstrepen WA, Nouwen EJ, De Broe ME. Deng JT, et al. Among authors: de broe me. Transplant Proc. 1994 Oct;26(5):2842-4. Transplant Proc. 1994. PMID: 7940895 No abstract available.

9

Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients.

Lefebure AF, Verpooten GA, Couttenye MM, De Broe ME. Lefebure AF, et al. Among authors: de broe me. Vaccine. 1993;11(4):397-9. doi: 10.1016/0264-410x(93)90278-6. Vaccine. 1993. PMID: 8470423 Clinical Trial.

10

Elevated plasminogen activator inhibitor levels in cyclosporin-treated renal allograft recipients.

Verpooten GA, Cools FJ, Van der Planken MG, Bedert LC, Claes R, Van Gaal LF, De Broe ME. Verpooten GA, et al. Among authors: de broe me. Nephrol Dial Transplant. 1996 Feb;11(2):347-51. doi: 10.1093/oxfordjournals.ndt.a027265. Nephrol Dial Transplant. 1996. PMID: 8671791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

439 results

Search Page

Filters